We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIEB icon
6551
Siebert Financial
SIEB
$68.4M
$20K ﹤0.01%
3,901
-1,168
-23% -$7.37K
SRET icon
6552
Global X SuperDividend REIT ETF
SRET
$231M
$20K ﹤0.01%
833
-5,435
-87% -$118K
TARA icon
6553
Protara Therapeutics
TARA
$232M
$20K ﹤0.01%
670
+298
+80% +$9.22K
TOKE
6554
DELISTED
Cambria Cannabis ETF
TOKE
$20K ﹤0.01%
1,602
-196
-11% -$2.3K
TECX
6555
Tectonic Therapeutic
TECX
$606M
$20K ﹤0.01%
98
-13,825
-99% -$2.85M
ICCH
6556
DELISTED
ICC Holdings, Inc.
ICCH
$20K ﹤0.01%
1,788
-132
-7% -$1.42K
KA
6557
DELISTED
Kineta, Inc. Common Stock
KA
$20K ﹤0.01%
107
+78
+269% +$15.9K
MMAT
6558
DELISTED
Meta Materials Inc. Common Stock
MMAT
$20K ﹤0.01%
277
+221
+395% +$17.4K
TTOO
6559
DELISTED
T2 Biosystems, Inc
TTOO
$20K ﹤0.01%
3
-18
-86% -$76.4K
HEWU
6560
DELISTED
iShares Currency Hedged MSCI United Kingdom ETF
HEWU
$20K ﹤0.01%
1,010
-2,717
-73% -$53K
RCA
6561
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
$20K ﹤0.01%
952
-1,048
-52% -$18.6K
PFHD
6562
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$20K ﹤0.01%
1,434
-900
-39% -$13.5K
VIVE
6563
DELISTED
VIVEVE MED INC
VIVE
$20K ﹤0.01%
3,585
+2,871
+402% +$18K
FMTX
6564
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$20K ﹤0.01%
+437
New +$18.9K
EEH
6565
DELISTED
ELEMENTS Linked to the SPECTRUM Large Cap U.S.Sector Momentum Index
EEH
$20K ﹤0.01%
960
-8
-0.8% -$175
CSLT
6566
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$20K ﹤0.01%
24,300
-60,462
-71% -$44.9K
OLD
6567
DELISTED
The Long-Term Care ETF
OLD
$20K ﹤0.01%
+841
New +$18.4K
ROCHU
6568
DELISTED
Roth CH Acquisition I Co. Unit
ROCHU
$20K ﹤0.01%
+2,029
New +$20.3K
DTUS
6569
DELISTED
iPath US Treasury 2-year Bear ETN
DTUS
$20K ﹤0.01%
872
+350
+67% +$7.83K
USLB
6570
DELISTED
Invesco Russell 1000 Low Beta Equal Weight ETF
USLB
$20K ﹤0.01%
652
-488
-43% -$14.3K
ACIU icon
6571
AC Immune
ACIU
$240M
$19K ﹤0.01%
2,825
+2,000
+242% +$14.5K
CWS icon
6572
AdvisorShares Focused Equity ETF
CWS
$133M
$19K ﹤0.01%
536
-378
-41% -$12.8K
ENTX icon
6573
Entera Bio
ENTX
$141M
$19K ﹤0.01%
+10,382
New +$21.2K
FOVL
6574
DELISTED
iShares Focused Value Factor ETF
FOVL
$19K ﹤0.01%
575
-367
-39% -$11.9K
FSZ icon
6575
First Trust Switzerland AlphaDEX Fund
FSZ
$37.5M
$19K ﹤0.01%
396
-547
-58% -$25.1K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.